1.
Venugopal V, MS J, Vidya T. Rosuvastatin Monotherapy Versus Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity, Vascular Inflammation, and Lipid Profile In Patients With Type 2 Diabetes Mellitus: A Randomised Controlled Trial. Adolescência e Saúde [Internet]. 2026 Sep. 23 [cited 2026 Sep. 26];:636-48. Available from: https://adolescenciaesaude.com/index.php/aes/article/view/2346